TMC Life Sciences (KLSE:TMCLIFE) said its profit attributable to owners plunged to 2.9 million ringgit in the fiscal first quarter ended Sept. 30 from 15.1 million ringgit a year earlier.
Earnings per share fell to 0.0017 ringgit, from 0.0087 ringgit a year ago, according to a Monday bourse disclosure.
Revenue shrank to 82 million ringgit from 92.4 million ringgit a year ago, the healthcare services provider said.
The board did not recommend a dividend for the period.
The company is a unit of Thomson Medical Group (SGX:A50).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments